-
Quality of Life and Productivity Costs in Cancer Patients Receiving Proton Therapy: A Predictive and Descriptive Study
Sep 9, 2025, 16:22 PM -
Indirect Costs Associated With Pneumococcal Disease: A Global Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Methodological Acceptability of the Economic Analyses Assessed by the HAS in 2024
Sep 9, 2025, 16:22 PM -
Humanistic and Economic Burden of Primary Biliary Cholangitis: A Systematic Review of Health-Related Quality of Life Healthcare Resource Utilization and Associated Cost
Sep 9, 2025, 16:22 PM -
Systematic Literature Review SLR Characterizing Humanistic Disease Burden and Unmet Needs in Erythropoietic Protoporphyria (EPP) and X-linked Protoporphyria (XLP)
Sep 9, 2025, 16:22 PM -
Budget Impact of the VELYS™ Robotic-Assisted Solution Compared to Manual Procedure in Patients Undergoing Primary Total Knee Arthroplasty in Italy
Sep 9, 2025, 16:22 PM -
The New Avenue for Access? European Market Access Routes Outside Traditional Public Payer Pathways
Sep 9, 2025, 16:22 PM -
Resistance-Driven Treatment Failure: A Challenge to HCV Elimination in Pakistan
Sep 9, 2025, 16:22 PM -
Measures for Integrating Carbon Footprints Into Economic Evaluations: A Targeted Review of Environmental and Economic Metrics
Sep 9, 2025, 16:22 PM -
Early Outpatient Follow-Up and Reduced Health Care Resource Utilization in Acute Heart Failure in Germany: A Descriptive Analysis
Sep 9, 2025, 16:22 PM -
Reducing Premature Cancer Mortality Through Early Stage Treatment: A Markov Model Analysis of Pembrolizumab Across Four Tumor Types
Sep 9, 2025, 16:22 PM -
From Deficit Risk to Surplus Strength: A Revenue-Centered Analysis of Türkiye’s General Health Insurance 2015-2024
Sep 9, 2025, 16:22 PM -
Global Evaluation of Flexible Cysto-Nephroscope Usage Patterns in Percutaneous Nephrolithotomy Procedures
Sep 9, 2025, 16:22 PM -
The Growing Role of Real-World Evidence (RWE) to Support Efficacy in EMA Oncology Approvals: Light at the End of the Tunnel
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life (HRQoL) and Its Associated Factors among Chinese Gout Patients: Baseline Findings From a Survey Study
Sep 9, 2025, 16:22 PM -
Qualitative Insights Into Artificial Intelligence (AI) and Virtual Reality (VR) Training for Value Communication: Comparing Innovative Technologies With Traditional Methods in Pharma
Sep 9, 2025, 16:22 PM -
Safety and Efficacy of Antibody Drug Conjugate (ADCs) in Pretreated Locally Advanced/Metastatic (LA/m) Triple-Negative Breast Cancer (TNBC): Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
Individual Therapy or No Therapy at All: Impact of Patient Individual Therapies As ACT in the German AMNOG Process
Sep 9, 2025, 16:22 PM -
Changes in Medical Technology Availability in Europe Between 2000 and 2020
Sep 9, 2025, 16:22 PM -
Mapping the Measurement Gap: Patient-Reported Outcomes Across the Obesity Care Continuum in the GLP-1 Era
Sep 9, 2025, 16:22 PM
